Schechter Adam H 4

What Happened
Adam H. Schechter, President & CEO of Labcorp (LH), had restricted stock units (RSUs) vest and converted 3,656 RSUs into common shares on Feb 11, 2026. On the same date he sold 5,273 shares in an open-market transaction at $284.38 per share, generating about $1,499,536. Separately, 1,521 shares were surrendered/withheld to satisfy tax obligations at an implied value of $289.89 per share (≈ $440,923). The filing was made on Feb 13, 2026.

Key Details

• Transaction date: 2026-02-11; Form 4 filed: 2026-02-13 (appears timely).
• Open-market sale: 5,273 shares @ $284.38 = $1,499,536.
• RSU conversion: 3,656 restricted stock units converted to common stock (derivative exercise/conversion).
• Tax withholding: 1,521 shares withheld to satisfy tax liability @ $289.89 ≈ $440,923.
• Footnotes: sale executed pursuant to a Rule 10b5-1 plan; each RSU equals one share; the vested RSUs were from a grant that vests in three equal annual installments beginning Feb 11, 2026.
• Shares owned after the transaction: not specified in the provided summary.

Context

• The “exercise/conversion” entries reflect RSUs vesting and being converted into common shares; the separate withholding entry is a tax-satisfaction action (not a cash payment).
• The open-market sale was executed under a 10b5-1 plan (prearranged trading plan), which is commonly used by insiders to sell shares on a set schedule and is typically considered routine.
• Sales by executives are not, by themselves, definitive signals about company outlook; purchases generally carry more weight for interpreting insider sentiment.